Compare AAL & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AAL | BAX |
|---|---|---|
| Founded | 1930 | 1931 |
| Country | United States | United States |
| Employees | 133700 | N/A |
| Industry | Air Freight/Delivery Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7B | 10.0B |
| IPO Year | 2004 | 1994 |
| Metric | AAL | BAX |
|---|---|---|
| Price | $18.08 | $21.32 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 18 | 9 |
| Target Price | $15.59 | ★ $21.00 |
| AVG Volume (30 Days) | ★ 130.8M | 6.5M |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $54,633,000,000.00 | $11,244,000,000.00 |
| Revenue This Year | $12.17 | $1.96 |
| Revenue Next Year | $4.62 | $2.22 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 0.78 | ★ 5.72 |
| 52 Week Low | $10.09 | $15.73 |
| 52 Week High | $18.05 | $31.44 |
| Indicator | AAL | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 80.04 | 61.70 |
| Support Level | $12.20 | $19.04 |
| Resistance Level | N/A | $22.41 |
| Average True Range (ATR) | 0.66 | 0.71 |
| MACD | 0.24 | 0.12 |
| Stochastic Oscillator | 94.95 | 70.54 |
American Airlines is the world's largest airline by aircraft, capacity, and scheduled revenue passenger miles. Its major US hubs are Dallas/Fort Worth, Charlotte, Chicago, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. It generates over 30% of US airline revenue connecting Latin America with destinations in the United States. After completing a major fleet renewal, the company has the youngest average fleet of US legacy carriers.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.